SAM
TGTX icon

Smartleaf Asset Management’s TG Therapeutics TGTX Stock Holding History

Smartleaf Asset Management’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$47.8K Sell
1,517
-1,630
-52% -$48.6K ﹤0.01% 1472
2025
Q4 		$93.6K Buy
3,147
+454
+17% +$14.8K ﹤0.01% 1223
2025
Q3 		$99.2K Buy
2,693
+467
+21% +$15.4K 0.01% 1078
2025
Q2 		$81.7K Sell
2,226
-190
-8% -$7.07K 0.01% 945
2025
Q1 		$96.3K Buy
2,416
+511
+27% +$17.2K 0.01% 848
2024
Q4 		$59.9K Buy
1,905
+1,594
+513% +$45.7K 0.01% 1096
2024
Q3 		$7.41K Buy
311
+63
+25% +$1.38K ﹤0.01% 1933
2024
Q2 		$4.45K Buy
248
+215
+652% +$3.43K ﹤0.01% 1860
2024
Q1 		$513 Buy
+33
New +$526 ﹤0.01% 1735

Other funds holding TGTX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return